Group 1 - The medical device sector experienced fluctuations, with the medical device ETF (562600) declining by 0.21%. However, Ji Min Health saw a strong surge, hitting the daily limit for five consecutive trading days, while Tuo Jing Life and An Jie Si also rose by over 6% [1] - In terms of capital flow, the medical device ETF (562600) had net inflows for four out of the last five trading days, accumulating 42.82 million yuan, and nine out of the last ten trading days, totaling 68.02 million yuan [1] - The recently released "Implementation Opinions on Promoting the Innovation and Development of Brain-Machine Interface Industry" aims for breakthroughs in key technologies by 2027, establishing advanced technical, industrial, and standard systems [1] Group 2 - The implementation opinions emphasize increased support for key products like implantable brain-machine interface medical devices, including expedited registration guidance and priority support [1] - According to Xinda Securities, the centralized procurement in the medical device sector is changing the competitive landscape, benefiting leading companies and accelerating domestic substitution [1] - The medical device industry is expected to transition from scale expansion to a higher level of development, with opportunities arising from technological platformization, AI diagnostics, and consumer healthcare extensions [1] Group 3 - The medical device ETF (562600) serves as a convenient tool for investors to capture growth opportunities in the medical device industry, tracking the CSI All Share Medical Device Index [2] - This ETF selects 100 representative listed companies in core medical fields, with the medical device sector accounting for 89.34% of the index, highlighting its concentrated structure [2]

龙虎榜数据显示，该股因连续三个交易日内，涨幅偏离值累计达20%、日涨幅偏离值达7%上榜龙虎榜2 次，买卖居前营业部中，机构净买入3375.02万元，营业部席位合计净卖出5398.04万元。 4月29日公司发布的一季报数据显示，一季度公司共实现营业总收入1.81亿元，同比下降22.49%，实现 净利润-0.14亿元，同比下降191.72%。7月12日公司公布了上半年业绩预告，预计实现净利润-0.55亿元 至-0.46亿元。（数据宝） 近日该股表现 （文章来源：证券时报网） 济民健康盘中涨停，已连收5个涨停板，截至14:41，该股报11.86元，换手率30.89%，成交量1.62亿股， 成交金额18.02亿元，涨停板封单金额为1.16亿元。连续涨停期间，该股累计上涨61.14%，累计换手率 为81.14%。最新A股总市值达62.28亿元。 证券时报·数据宝统计，两融数据来看，该股最新（8月19日）两融余额为2.18亿元，其中，融资余额 2.18亿元，较前一个交易日增加357.17万元，环比增长1.67%，近5日累计增加5577.80万元，环比增长 34.49%。 | 日期 | 当日涨跌幅（%） | 换手率（%） ...

Market Overview - Major market indices opened lower, with the Shanghai Composite Index down 0.28% at 3716.68 points, the Shenzhen Component Index down 0.61% at 11749.99 points, and the ChiNext Index down 1.14% at 2572.01 points [1]. Stock Performance - A total of 1167 stocks rose at the opening, with newly listed stock N Hongyuan surging 305.67% at the open. There were 9 stocks hitting the daily limit up, including *ST Aowei with 11 consecutive limit ups, Kosen Technology with 4 consecutive limit ups, and ST Dongshi with 3 limit ups in 4 days [1]. - Conversely, 3502 stocks opened lower, with 2 stocks, *ST Gaohong and *ST Nanzhi, hitting the daily limit down [1]. Price Continuity - Among the stocks that hit the limit up yesterday, those that continued to hit the limit up today included Kosen Technology and Shimao Energy, totaling 6 stocks. Stocks that opened lower included Zhongheng Electric, Haili Shares, and Jimin Health, with declines of 8.29%, 5.52%, and 5.19% respectively [1]. - Stocks that hit the limit down yesterday and continued to do so today included *ST Gaohong and *ST Nanzhi [1].

Core Viewpoint - The stock of Jimin Health Management Co., Ltd. experienced abnormal trading fluctuations, with a cumulative closing price increase exceeding 20% over two consecutive trading days, prompting a risk warning to investors [2][3]. Group 1: Stock Trading Abnormalities - The company's stock price increased by 53.78% from August 13 to August 19, 2025, with significant deviations from the market and sector trends [2][7]. - The stock's closing price deviation reached a cumulative value of 20% on August 18 and 19, 2025, qualifying as an abnormal trading situation under the Shanghai Stock Exchange rules [3][4]. Group 2: Company Verification and Confirmation - The company conducted a self-examination and confirmed that there were no significant changes in its main business or external operating environment, and no undisclosed major matters exist [4][5]. - The company received written confirmation from its controlling shareholder and actual controller, stating that there are no undisclosed major asset restructurings, share issuances, or significant transactions [4][5]. Group 3: Financial Performance Risks - The company reported a net loss of 59.71 million yuan for the fiscal year 2024 and anticipates a net loss between 55 million yuan and 46 million yuan for the first half of 2025, indicating a decline compared to the previous year [2][7]. - The recent stock price increase is not aligned with the company's fundamental performance, suggesting a risk of short-term price correction [2][7].

证券代码：603222 证券简称：济民健康 公告编号：2025-038 济民健康管理股份有限公司 ●公司股票交易于2025年8月18日、8月19日连续二个交易日内收盘价格涨幅 偏离值累计超过20%，属于《上海证券交易所交易规则》规定的股票交易异常波动 情形。 ●经公司自查并书面征询控股股东及实际控制人，截至本公告披露日，公司 不存在应披露而未披露的重大事项。 ●股价累计涨幅较大风险。自 2025 年 8 月 13 日至 2025 年 8 月 19 日，公司 股票收盘价格累计涨幅达 53.78%，并连续两次触及异动，公司股价剔除大盘和板 块整体因素后的实际波动幅度较大。敬请广大投资者注意二级市场交易风险，理 性决策，审慎投资。 ●经营亏损风险。2024 年度归属于母公司所有者的净利润为-5,971.17 万元； 2025 年半年度，公司预计实现归属于母公司所有者的净利润为-5,500 万元至 -4,600 万元，与上年同期相比，将出现亏损。 公司近期股价涨幅与基本面偏离，公司主营业务未发生重大变化，公司股价 存在短期上涨过快的风险。敬请广大投资者注意二级市场交易风险，理性决策， 审慎投资。 一、股票交易异常波动 ...

济民健康管理股份有限公司: 关于济民健康管理股份有限公司 · 股票交易异常波动的征询函的回函 本公司持有济民健康管理股份有限公司 24. 37%的股份,为济民健康管理股 份有限公司控股股东。 本公司于 2025 年 8 月 19 日收到你公司发来的《关于济民健康管理股份有 限公司股票交易异常波动的征询函》,现就你公司征询事项回复如下; 一、本公司不涉及你公司的应披露而未披露的重大信息,不存在针对你公司 的重大资产重组、发行股份、上市公司收购、债务重组、业务重组、资产剥离和 资产注入等重大事项。 二、无其他重大事项。 股票交易异常波动的征询函的回函 济民健康管理股份有限公司: 本家族成员直接持有济民健康管理股份公司(以下简称"公司")股份 7,727.70万股,占公司总股本的 14.72%,并持有公司控股股东双鸽集团有限公 司 100%的股权和法人股东台州市梓铭贸易有限公司 100%的股权,为公司实际控 制人。 本家族全体成员于 2025年8月19 日收到你公司发来的《关于济民健康管理 股份有限公司股票交易异常波动的征询函》,现就你公司征询事项回复如下: 一、本家族全体成员不存在应披露而未披露的重大信息,包括但 ...

Market Overview - A total of 85 stocks hit the daily limit up, while 35 stocks faced limit down, resulting in a sealing rate of 71% [1] - The market experienced a slight decline with the Shanghai Composite Index down 0.02%, the Shenzhen Component Index down 0.12%, and the ChiNext Index down 0.17% [1] - The total trading volume for the day was 2.59 trillion yuan, a decrease of 175.8 billion yuan compared to the previous trading day, marking the fifth consecutive day of trading volume exceeding 2 trillion yuan [1] Stock Performance - Notable stocks with consecutive limit ups include Jimin Health with 4 consecutive limit ups and Shenlian Bio with 3 consecutive limit ups [1][3] - The highest number of consecutive limit ups was observed in stocks like Guojijingong with 12 days and 7 limit ups, and Huasheng Tianc with 9 days and 6 limit ups [1] - The market saw over 2900 stocks rising, with sectors such as liquor, Huawei HiSilicon, CPO, and humanoid robots performing well, while insurance, military, securities, and gaming sectors faced declines [1] Sector Analysis - The AI and manufacturing sectors are gaining traction, with the Shanghai Municipal Economic and Information Commission supporting the deployment of industrial robots in high-risk work scenarios [5] - The upcoming 2025 China Computing Power Conference is expected to highlight the growth of the AI computing power market, projected to reach 25.9 billion USD by 2025, a 36.2% increase year-on-year [6] - Huawei's ecosystem continues to thrive, with over 10 million devices equipped with HarmonyOS 5, leading to a surge in related stocks such as Huasheng Tianc and Sichuan Changhong [7] Consumer Sector Insights - The State Council emphasized the need to stimulate consumer potential, which has positively impacted liquor stocks, with brands like Jiugui Liquor and Shede Liquor seeing significant gains [8] - Despite previous challenges faced by the liquor industry, the upcoming Mid-Autumn Festival and National Day are expected to boost consumer spending [8] Technical Analysis - The market showed a pattern of high volatility, with major indices reaching new highs before experiencing pullbacks, indicating strong selling pressure at higher levels [9] - The technical indicators suggest that the indices may need to test support levels around the 20-hour and 5-day moving averages in the short term [9]

Group 1 - The medical device sector experienced a volatile pullback on August 19, with the medical device ETF (562600) declining by 2.13%. However, stocks such as Tsinghua Tongfang and Furuide surged to a 20% limit up, while Jimin Health and Blue Sail Medical reached a 10% limit up [1] - Over the past five trading days, there have been net inflows into the medical device ETF for four days, accumulating a total of 36.79 million yuan. In the last ten trading days, there were net inflows for eight days, totaling 52.49 million yuan [1] - On August 15, Hainan Province announced new policies to support the high-quality development of the biopharmaceutical industry, effective from September 13 for three years. The policies include a reward of up to 3% of actual sales for companies participating in national centralized procurement, with a maximum reward of 3 million yuan [1] Group 2 - The medical device ETF (562600) serves as a convenient tool for investors to capture growth opportunities in the medical device industry, tracking the CSI All Share Medical Device Index, which includes 100 representative listed companies in core medical fields [2] - The medical device industry accounts for a significant 89.34% of the index, indicating a high concentration that allows for precise capture of development dividends in the medical device sector [2]

从资金流向上来看，当日医疗器械板块主力资金净流出4.08亿元，游资资金净流入1.11亿元，散户资金净 流入2.98亿元。医疗器械板块个股资金流向见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300642 | 透景生命 | 23.09 | 20.01% | 29.76万 | | 6.45亿 | | 300049 | 福瑞股份 | 72.23 | 20.00% | 15.94万 | | 11.27亿 | | 872925 | 锦好医疗 | 30.18 | 18.63% | 5.47万 | | 1.54亿 | | 836504 | 博迅生物 | 34.03 | 18.20% | 7.51万 | | 2.62亿 | | 603222 | 济民健康 | 10.78 | 10.00% | 45.53万 | | 4.87亿 | | 002382 | 蓝帆医疗 | 6.74 | 9.95% | 75.54万 | | 4.95亿 | | 301093 | 华兰股份 | 32.55 | ...

Group 1 - The China Securities Index for healthcare equipment and services has shown a positive trend, with notable stock increases such as 20.01% for Toujing Life and 20.00% for Furuijian [1] - The Ministry of Industry and Information Technology, along with six other departments, has issued implementation opinions to promote the innovation and development of the brain-computer interface industry, aiming for breakthroughs in key technologies by 2027 [1] - The brain-computer interface technology is experiencing rapid changes, with expectations for significant market expansion as domestic companies move towards commercial applications [1] Group 2 - Recent performance forecasts in the medical consumables sector indicate that low-value consumables are affected by US-China tariff policies, while high-value consumables are gradually recovering from centralized procurement impacts [2] - The optimization of centralized procurement policies in the pharmaceutical sector is expected to restore market confidence in the entire consumables industry [2] - The China Construction Bank's ETF closely tracks the China Securities Index for healthcare equipment and services, reflecting the overall performance of listed companies in this sector [2]